CHRISTY HAGER: Open Payments
NPI 1073121182 · MANCHESTER, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,231 in 67 payments from 20 companies in 2025. Trend: 2023 $831 · 2024 $892 · 2025 $1,231
Food & beverage: $1,231
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $218 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $173 |
| Lundbeck LLC | 6 | $113 |
| Otsuka America Pharmaceutical, Inc. | 6 | $96 |
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| Sumitomo Pharma America, Inc. | 4 | $79 |
| Axsome Therapeutics, Inc. | 4 | $76 |
| PFIZER INC. | 4 | $75 |
| Lilly USA, LLC | 3 | $56 |
| Exact Sciences Corporation | 2 | $35 |
Products named: REXULTI, CAPLYTA, VRAYLAR, GEMTESA, NURTEC ODT, QULIPTA, UBRELVY, MOUNJARO.
Industry payments across TN — which companies pay providers there.
